142 related articles for article (PubMed ID: 37977907)
1. Predictors of treatment response in therapy-resistant enuresis.
Uhrenius I; Bergsten A; Nevéus T
J Pediatr Urol; 2024 Apr; 20(2):219.e1-219.e6. PubMed ID: 37977907
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of voiding chart data in therapy-resistant enuresis.
Lundmark E; Neve Us T
J Pediatr Urol; 2020 Jun; 16(3):353.e1-353.e6. PubMed ID: 32423706
[TBL] [Abstract][Full Text] [Related]
3. Alarm interventions for nocturnal enuresis in children.
Caldwell PH; Codarini M; Stewart F; Hahn D; Sureshkumar P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002911. PubMed ID: 32364251
[TBL] [Abstract][Full Text] [Related]
4. Reboxetine in therapy-resistant enuresis: A randomized placebo-controlled study.
Lundmark E; Stenberg A; Hägglöf B; Nevéus T
J Pediatr Urol; 2016 Dec; 12(6):397.e1-397.e5. PubMed ID: 27544904
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic and related drugs for nocturnal enuresis in children.
Caldwell PH; Sureshkumar P; Wong WC
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD002117. PubMed ID: 26789925
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
7. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
[TBL] [Abstract][Full Text] [Related]
8. Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics).
Deshpande AV; Caldwell PH; Sureshkumar P
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002238. PubMed ID: 23235587
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
Hara T; Ohtomo Y; Endo A; Niijima S; Yasui M; Shimizu T
J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
[TBL] [Abstract][Full Text] [Related]
10. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
11. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
[TBL] [Abstract][Full Text] [Related]
12. Management of nocturnal enuresis in Greek children.
Triantafyllidis A; Charalambous S; Papatsoris AG; Papathanasiou A; Kalaitzis C; Rombis V; Touloupidis S
Pediatr Nephrol; 2005 Sep; 20(9):1343-5. PubMed ID: 15973527
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin for nocturnal enuresis in children.
Glazener CM; Evans JH
Cochrane Database Syst Rev; 2000; 2002(2):CD002112. PubMed ID: 10796860
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin resistant enuresis: pathogenetic and therapeutic considerations.
Nevéus T; Läckgren G; Tuvemo T; Olsson U; Stenberg A
J Urol; 1999 Dec; 162(6):2136-40. PubMed ID: 10569604
[TBL] [Abstract][Full Text] [Related]
15. A prospective and randomized study comparing the use of alarms, desmopressin and imipramine in the treatment of monosymptomatic nocturnal enuresis.
Mello MF; Locali RF; Araujo RM; Reis JN; Saiovici S; Mello LF; Trigo Rocha FE
J Pediatr Urol; 2023 Jun; 19(3):241-246. PubMed ID: 36717289
[TBL] [Abstract][Full Text] [Related]
16. Management of treatment-resistant nocturnal enuresis.
Tsuji S; Kaneko K
Pediatr Int; 2023; 65(1):e15573. PubMed ID: 37428825
[TBL] [Abstract][Full Text] [Related]
17. The value of case history and early treatment data as predictors of enuresis alarm therapy response.
Larsson J; Borgström M; Karanikas B; Nevéus T
J Pediatr Urol; 2023 Apr; 19(2):173.e1-173.e7. PubMed ID: 36470786
[TBL] [Abstract][Full Text] [Related]
18. Bladder capacity and renal concentrating ability in enuresis: pathogenic implications.
Nevéus T; Tuvemo T; Läckgren G; Stenberg A
J Urol; 2001 Jun; 165(6 Pt 1):2022-5. PubMed ID: 11371921
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
Gözüküçük A; Kılıç M; Çakıroğlu B
J Pediatr Urol; 2021 Aug; 17(4):451.e1-451.e6. PubMed ID: 33931318
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal enuresis and the use of desmopressin: is it helpful?
Bath R; Morton R; Uing A; Williams C
Child Care Health Dev; 1996 Mar; 22(2):73-84. PubMed ID: 8820012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
